CRO Analytics Appoints Bruce Wakeman as CCO

CRO Analytics, a provider of clinical research quality performance indicators, has appointed Bruce Wakeman chief commercial officer. Mr. Wakeman will be responsible for CRO Analytics’ overall commercial strategy and execution, and will implement marketing, sales, and commercial operations and infrastructure for the launch of the company’s flagship product, Performer. 

Most recently, Mr. Wakeman served as vice president, U.S. business development at Worldwide Clinical Trials. His twenty-year career spans proposal and contract development, clinical operations, business development and sales. Prior to Worldwide, he held a variety of senior business development roles, including U.S. leadership at both large and specialized CROs, and led strategic development initiatives.

Mr. Wakeman’s hiring coincides with the launch of the company’s flagship product, Performer.  The cloud-based enterprise offering is first clinical trial quality system (CTQS) and first application to collect and report quality performance indicators (QPIs). Performer is currently in use in several pilot programs and has been used to collect data on the first ever clinical trial industry quality assessment with Applied Clinical Trials. The company recently announced a collaboration with the Association of Clinical Research Professionals to develop a new instrument for investigative sites to assess clinical trial quality.